FORT WORTH, Texas, Sept. 30 /PRNewswire/ — Healthpoint today
announced that the results of a new study conducted by Catherine T.
Milne APRN, MSN, CWOCN, BC-ANP, will be presented on Thursday,
September 30, 2010 at 7:15pm (Eastern) at the Healthpoint booth
(#110) during the 25th Annual Clinical Symposium on Advances in
Skin & Wound Care: The Conference for Prevention and Healing.
The conference is being held from September 30 to October 3, 2010,
at the Gaylord Palms Resort & Convention Center in Orlando,
Florida. Ms. Milne will also deliver encore presentations of her
study results at 11:15am (Eastern) on Friday, October 1st, and
12:45pm (Eastern) on Saturday, October 2nd; all presentations will
be held in The Wound Institute® Theatre located inside of the
Healthpoint booth.
The study was designed to evaluate the comparative efficacy of
Collagenase SANTYL® Ointment to a hydrogel dressing as measured
by time to complete wound debridement (dead tissue removal) of
pressure ulcers. Twenty-seven nursing home residents were enrolled
and randomized to receive either Collagenase SANTYL® Ointment
(N=13) — an enzymatic debriding agent — or a hydrogel dressing
(N=14). Investigators blinded to randomization evaluated weekly
wound photographs using a digital planimetry software package for
debridement. The Collagenase-treated group achieved statistical
significance in complete debridement by day 42 as compared to the
hydrogel-treated group (p<.003); eleven of the 13
Collagenase-treated patients (85%) vs. four of the 14
hydrogel-treated patients (29%) experienced complete debridement by
day 42.
“To date, studies comparing Collagenase to hydrogel have not
been reported in the literature,” noted Catherine T. Milne, APRN,
MSN, CWOCN of the Bristol Hospital Wound, Ostomy, Lymphedema Center
in Bristol, Connecticut and the study’s principal investigator.
“The findings of the present study are particularly relevant for
clinicians in the long
‘/>”/>
